Yosemite

Daymark Health is a value-based oncology company redefining the cancer care experience for patients, providers, and health plans.

Tune Therapeutics is focused on developing innovative cell and gene therapies that utilize epigenetic programming to address serious diseases. By harnessing the epigenome, the company aims to create new pathways for treatment without making changes to the DNA sequence itself. This approach allows for the potential development of therapies for complex and widespread medical conditions, positioning Tune Therapeutics at the forefront of advancements in the field of epigenetics.

Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.

Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, the company has created a marketplace that connects patients, providers, and payers. Its platform allows users to browse and compare prices for elective services offered by hospitals, as well as to compare insurance services. This functionality enables individuals to save money on elective treatments and helps healthcare organizations attract both cash-paying and insured patients. Turquoise Health aims to enhance transparency in healthcare pricing, ultimately benefiting all stakeholders involved.

Maia Oncology is a virtual onco-primary care clinic that focuses on providing comprehensive care for cancer patients and survivors. The clinic operates a platform designed to coordinate cancer care, tracking important patient outcomes such as hospitalizations, emergency room visits, and the emergence of new comorbidities. This approach helps patients manage the complexities and long-term effects associated with cancer treatment. By offering a supportive environment, Maia Oncology aims to enhance the navigation of treatment-related challenges and improve overall patient well-being.